Torrent Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts

Torrent Pharmaceuticals Ltd. Conference Calls and Earnings Call Transcripts: Get insights into company performance, financials, capex plans, and more.

announcement
Conference/Earnings Calls Alerts
3439.60
1.02%
3439.60
1.02%
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.
3439.60
1.02%
3439.60
1.02%
TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
BSE India
In continuation of our letter dated 16-May-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Transcript of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2023, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Earnings_Call_Transcript_May_30_2023.pdf
3439.60
1.02%
TORRENT PHARMACEUTICALS LTD. - 500420 - Audio Recording Of Conference Call With Analysts / Investors On …
BSE India
In continuation to our letter dated 16-May-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Audited Financial Results of the Company for the quarter and year ended 31st March, 2023, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording31032023.mp3
3439.60
1.02%
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q4FY23 Performance and Outlook. Listen to the full earnings transcript.
3439.60
1.02%
3439.60
1.02%
TORRENT PHARMACEUTICALS LTD. - 500420 - Audio Recording Of Conference Call With Analysts / Investors On …
BSE India
In continuation of our letter dated 12-Jan-23 and pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the audio recording of Conference call with Analysts / Investors on Financial Results of the Company for the quarter and nine months ended 31st December, 2022, has been placed on the Company's website at https://www.torrentpharma.com/pdf/investors/Audio_Recording31122022.mp3
3439.60
1.02%
Conference Call with Torrent Pharmaceuticals Management and Analysts on Q3FY23 Performance and Outlook. Listen to the full earnings transcript.
3439.60
1.02%

Earnings Calls Podcast on